Home » Market News » Asian Markets inch Higher on Covid-19 Vaccine News

Asian Markets inch Higher on Covid-19 Vaccine News

asian

The Asian and Pacific Rim was mostly higher by the late morning on Tuesday. Traders are monitoring positive Covid-19 (coronavirus) vaccine news which is boosting sentiment and at-risk assets like equities.

In Japan, the Asian benchmark the Nikkei 225 was up 0.39 percent and the shares on the broader Topix index, in Tokyo, rose 0.27 percent. Shares of Fujifilm rose better than four percent after news that U.S. President Donald Trump announced they were awarding the company a a $265 million contract for coronavirus vaccine manufacturing.

The South Korean Kospi composite index led the Asian and Pacific Rim as shares gained 1.92 percent. Shares of Samsung Electronics popped over five percent in the morning.

In Australia, the headline ASX 200 was up 0.95 percent and in Hong Kong, the Hang Seng index was up 0.97 percent.

In China, the Shanghai composite is up half a percent and the Shenzhen component is trading up by 1.166 percent by the late morning.

Asian Traders continue to Monitor Covid-19 Headlines

The coronavirus is still a factor with financial market sentiment. Yesterday, U.S. Senate Majority Leader Mitch McConnell on Monday unveiled the GOP coronavirus stimulus bill.

The GOP bill provides basic relief for unemployed Americans as well as other provisions to support the economy. The United States currently leads the world with the number of coronavirus infections and deaths around the world.

Traders Monitor Covid-19 Vaccine Developments

There are positive developments with a possible coronavirus vaccine. The end result is still sometime away, however. Several bio-tech firms are reporting that they have started late-stage human trials as the race to find a cure is heating up.

U.S. drug maker Pfizer and German biotech firm BioNTech have said that they are now starting their stage three trials with human testing. They announced this overnight. Other companies in England and the U.S. firm Moderna are also reporting positive results with testing.

About David Frank

David has his MA and PhD in Economics. He is a technical analyst who has been trading in the Forex world for over a decade. As an analyst and trader, David believes in the big picture by blending together technical analysis with the fundamentals behind the scenes in the Forex and Bond markets. David’s trading strategy is unique. He blends an understanding of fundamental and macroeconomics with technical analysis to offer a unique view into Forex. He applies several strategies including carry long positions, to take advantage of high yields in non-volatile markets, as well as using quicker, chart related analysis for day trading.

Check Also

euro

Euro Currency falls below 1.2080 to Challenge 1.2070

0.0 00 Looking at the benchmark EUR/USD currency exchange rate, the euro currency has fallen …